No insider purchase over the last 90 days. The latest, by WP X Biologics LLC, was filed 15 May 2013.
China Biologic Products, Inc. is a listed company. Its insiders report their share dealings to SEC (Form 4). No insider at China Biologic Products, Inc. has published a filing in the past twelve months. The most recent one dates from 10 May 2017.
The full history, which starts in 2009, counts 31 purchases against 79 sales.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended December 2019 · cache
25 of 192 declarations
China Biologic Products, Inc. is a company specializing in the production of blood-derived biological products in China. It focuses on the research, development, manufacturing, and sale of plasma-based therapeutic products.